Report overview
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
This report aims to provide a comprehensive presentation of the global market for Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Vaccines. This report contains market size and forecasts of Cancer Vaccines in global, including the following market information:
Global Cancer Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cancer Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Cancer Vaccines companies in 2022 (%)
The global Cancer Vaccines market was valued at US$ 4893.2 million in 2022 and is projected to reach US$ 12040 million by 2029, at a CAGR of 13.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient's immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Global Cancer Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
Cervical Cancer
Prostate Cancer
Others
Global Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Vaccines revenues share in global market, 2022 (%)
Key companies Cancer Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Vaccines, market overview.
Chapter 2: Global Cancer Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
